Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Teladoc Adds To Its Services With Tailored Nutrition Plans

Published 12/04/2019, 10:05 PM
Updated 07/09/2023, 06:31 AM

Teladoc Health, Inc. (NYSE:TDOC) continued the extension of its clinical services with the launch of Teladoc Nutrition, a series of customized nutrition counselling solutions accompanied with specialized care from a registered dietitian.

Lack of proper diet is one of the major reasons for complicated health situations among Americans. With this virtual access to nutrition services, the company’s current suite of healthcare solutions is expected to encourage better long-term health outcomes.

The company is also likely to lower overall medical expenditure with this strategic move, especially for patients with chronic and complex health conditions.

This action will benefit patients through an array of enhanced clinical services offered by Teladoc, which in turn, would enrich their experiences and produce better health results. A personalized nutrition plan would cater to their individual unique health needs.

Members availing this nutrition service will directly work with accredited registered dietitians (RDs) compared with nutritionists or wellness coaches. They will assess clinical nutrition requirements and plan personalized programs on the basis of updated, science-based guidelines congruent with the Academy of Nutrition and Dietetics. These services even help reduce long-term medical costs.

This service will broaden Teladoc’s existing portfolio of products and services including clinical conditions, telehealth solutions, expert medical services, behavioral health solutions, guidance and support plus platform and program services.

The company is fast gaining ground in the rapidly growing telehealth services industry in the United States with ample scope to flourish owing to rising health care costs following inefficient care, duplication of services, significant waste and extreme variation in access, cost and quality of care.

Shares of this Zacks Rank #3 (Hold) stock have surged 43.5% in a year’s time against the industry’s decline of 19.3%.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Stocks to Consider

Investors interested in the medical sector can take a look at some better-ranked stocks like LHC Group, Inc. (NASDAQ:LHCG) , Amedisys, Inc. (NASDAQ:AMED) and CRH (LON:CRH) Medical Corporation (NYSE:CRHM) .

LHC Group specializes in the post-acute continuum of care, primarily for Medicare beneficiaries in the United States. The company has a Zacks Rank #1 (Strong Buy) and average four-quarter beat of 8.1%. You can see the complete list of today’s Zacks #1 Rank stocks here.

Amedisys provides healthcare services in the United States. In the trailing four quarters, the company’s average beat was 21.1%. It sports a Zacks Rank of 1.

CRH Medical Corporation delivers products and services to gastroenterologists in the United States and Canada. In the last four quarters, the company’s average beat was 50%. It carries a Zacks Rank #2 (Buy).

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



CRH Medical Corporation (CRHM): Free Stock Analysis Report

LHC Group, Inc. (LHCG): Free Stock Analysis Report

Amedisys, Inc. (AMED): Free Stock Analysis Report

Teladoc Health, Inc. (TDOC): Free Stock Analysis Report
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.